Tag Archives: obstructive sleep apnea

EQT Leads Investment in Mosanna to Advance Nasal Spray Therapy for Sleep Apnea Patients

(IN BRIEF) EQT Life Sciences has led a Series A investment in Mosanna Therapeutics to advance its lead drug candidate, MOS118—a nasal spray designed to treat obstructive sleep apnea—into Phase 2 trials. Co-investors include Pivotal bioVenture Partners, Forbion, Norwest, and … Read the full press release

EIB Invests €37.5 Million in Nyxoah’s Innovative Sleep Apnea Solutions

(IN BRIEF) The European Investment Bank (EIB) has awarded Belgium-based medtech company Nyxoah €37.5 million in venture-debt financing to support the development of innovative treatments for obstructive sleep apnea (OSA). This funding, backed by the InvestEU Life Sciences programme, will … Read the full press release